Skip to main content

Novonesis

Novonesis (formed via the combination of Novozymes A/S and Chr. Hansen Holding A/S) is a Danish biosolutions enterprise that produces specialized biological enzymes, microbials, and cultures. The company organizes its global operational activities across reportable segments comprising Food & Beverage Biosolutions, Human Health Biosolutions, Agriculture & Industrial Biosolutions, and Planetary Health Biosolutions. Its core product portfolio encompasses industrial enzymes, microbial cultures, probiotics, natural food colors, functional proteins, and bio-agricultural crop protection solutions. Principal revenue drivers consist of high-margin commercial sales of biological ingredients and enzyme formulations to industrial processing manufacturers and global consumer goods brands. Novonesis serves diverse end markets encompassing food and beverage processing, detergent and household care manufacturing, bioenergy production, animal nutrition, and dietary health supplements. The enterprise maintains a market-leading global position as the world's largest dedicated manufacturer of industrial enzymes and functional microbials across global industrial markets. Headquartered in Bagsvaerd, Denmark, the company's B common shares are publicly traded on the Nasdaq Copenhagen exchange under the ticker symbol ONSIS B (formerly NZYM B).

122 of the funds FundTelligence covers report a position in Novonesis.

Sector
Materials
Country
Denmark
Funds holding it
122
Exposure themes
Bio-based & Resource-Efficient Production, Bioenergy & Renewable Fuels, Circular Economy, Circular Materials & Resource Efficiency, Energy Production, Energy Transition, Agricultural Technology & Inputs, Food & Agriculture Transformation, Inputs & Biologicals

Funds holding Novonesis

Showing the 8 largest of 122 funds holding it.

Loading...